XML 28 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 6 Months Ended
Apr. 30, 2012
Apr. 30, 2011
Apr. 30, 2012
Apr. 30, 2011
Revenues (1):        
Product sales and revenues $ 22,111 $ 26,673 $ 51,711 $ 52,433
Research and development contracts 2,042 1,934 3,779 4,254
Total revenues 24,153 [1] 28,607 [1] 55,490 [1] 56,687 [1]
Costs of revenues:        
Cost of product sales and revenues 22,081 37,460 49,741 65,519
Cost of research and development contracts 1,871 2,017 3,444 4,354
Total costs of revenues 23,952 39,477 53,185 69,873
Gross profit (loss) 201 (10,870) 2,305 (13,186)
Operating expenses:        
Administrative and selling expenses 4,002 4,454 7,766 8,504
Research and development expenses 3,956 4,498 7,739 8,744
Total costs and expenses 7,958 8,952 15,505 17,248
Loss from operations (7,757) (19,822) (13,200) (30,434)
Interest expense (575) (928) (1,205) (982)
Loss (gain) from equity investment (150) 143 (512) (55)
License fee and royalty income 412 382 836 788
Other income (expense), net (414) 226 (218) 202
Loss before redeemable preferred stock of subsidiary     (14,299) (30,481)
Accretion of redeemable preferred stock of subsidiary     0 (525)
Loss before benefit (provision) for income taxes (8,484) (19,999) (14,299) (31,006)
Benefit (provision) for income taxes 121 (9) (78) (9)
Net Loss (8,363) (20,008) (14,377) (31,015)
Net loss attributable to noncontrolling interest 71 52 142 121
Net loss attributable to FuelCell Energy (8,292) (19,956) (14,235) (30,894)
Adjustment for modification of redeemable preferred stock of subsidiary 0 (8,987) 0 (8,987)
Preferred stock dividends (801) (800) (1,601) (1,600)
Net loss to common shareholders $ (9,093) $ (29,743) $ (15,836) $ (41,481)
Loss per share basic and diluted        
Net loss per share to common shareholders $ (0.06) $ (0.24) $ (0.11) $ (0.35)
Basic and diluted weighted average shares outstanding 150,013,074 125,009,180 144,830,437 119,963,394
[1] Includes revenue from a related party. Refer to Concentrations in note 1 to the financial statements.